Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect

British Journal of Dermatology | Sep 13, 2019 Clinical Pharmacology

Treatment of rosacea and demodicosis with benzyl benzoate: Effects of different doses on Demodex density and clinical symptoms

Journal of the European Academy of Dermatology and Venereology | Sep 13, 2019 Clinical Pharmacology

Guselkumab vs secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomised controlled trial

The Lancet | Sep 12, 2019 Clinical Pharmacology

Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Journal of the European Academy of Dermatology and Venereology | Sep 12, 2019 Clinical Pharmacology

Effectiveness and safety of olive oil preparation for topical use in pressure ulcer prevention: Multicentre, controlled, randomised, and double-blinded clinical trial

International Wound Journal | Sep 09, 2019 Clinical Pharmacology

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment

Cancer Management and Research | Sep 03, 2019 Clinical Pharmacology

Monotherapy for toenail onychomycosis: A systematic review and network meta-analysis

British Journal of Dermatology | Aug 30, 2019 Clinical Pharmacology

Role of ¹⁸F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for the detection of recurrent disease after treatment of malignant melanoma

Oncology | Aug 29, 2019 Clinical Pharmacology

Long-term clinical outcomes of imiquimod 5% cream vs diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials

Journal of the European Academy of Dermatology and Venereology | Aug 27, 2019 Clinical Pharmacology

Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Journal of the European Academy of Dermatology and Venereology | Aug 27, 2019 Clinical Pharmacology

« Prev 1 … 48 49 50 51 52 … 92 Next »

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect

Treatment of rosacea and demodicosis with benzyl benzoate: Effects of different doses on Demodex density and clinical symptoms

Guselkumab vs secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomised controlled trial

Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Effectiveness and safety of olive oil preparation for topical use in pressure ulcer prevention: Multicentre, controlled, randomised, and double-blinded clinical trial

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment

Monotherapy for toenail onychomycosis: A systematic review and network meta-analysis

Role of ¹⁸F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for the detection of recurrent disease after treatment of malignant melanoma

Long-term clinical outcomes of imiquimod 5% cream vs diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials

Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect

Treatment of rosacea and demodicosis with benzyl benzoate: Effects of different doses on Demodex density and clinical symptoms

Guselkumab vs secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomised controlled trial

Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Effectiveness and safety of olive oil preparation for topical use in pressure ulcer prevention: Multicentre, controlled, randomised, and double-blinded clinical trial

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment

Monotherapy for toenail onychomycosis: A systematic review and network meta-analysis

Role of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for the detection of recurrent disease after treatment of malignant melanoma

Long-term clinical outcomes of imiquimod 5% cream vs diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials

Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic

Role of ¹⁸F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for the detection of recurrent disease after treatment of malignant melanoma